In 2025, drug approvals widen treatment options for chronic diseases, infections and pain, including Ozempic kidney ...

The Food and Drug Administration rolled out a rapid-fire series of moves this month that could reshape how Americans manage ...

Pro-life groups are holding the U.S. Food and Drug Administration and its commissioner Marty Makary accountable for leaving ...

The Philadelphia Phillies’ superstar might have risked "neurological complications” with an unapproved health procedure.

Cynata Therapeutics has achieved a major catalyst for 2025 by completing patient enrolment in its Phase II clinical trial of ...

A mom was overjoyed when she learned a gene therapy treatment could save her child's life, until she found out no one would ...

Ground-breaking research sits at the core of the Harry Perkins Institute of Medical Research which has reported a series of notable scientific advances.

( WHTM) — The U.S. Food & Drug Administration (FDA) announced that White Castle has recalled more than 1,000 cases of its ...

Sevabertinib showed promise in early trials for non-squamous non-small-cell lung cancer with HER2 mutations. Read more at ...

After 17 years of service to his country filled with physical and mental strain, a retired Navy SEAL was contemplating ...

“Reckless” and “dangerous” were just two of the broadsides American medical groups lobbed at Robert F. Kennedy Jr.’s vaccine ...

Trump's decision to move marijuana to Schedule III could ease taxes and expand medical access, but industry leaders warn it ...